Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 20,100 | reported | 02 Jun 2026 | tx 8+80,633−6,333 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jun 2026 | GRANT_AWARD | Avalo Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,166 | — | |
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,166 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 3,167 | — | |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 3,167 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 9,500 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 24,600 | 0.00 USD | deriv |